Société Générale — M&A Activity 2021

Jun 4, 2021

National Storage Mechanism | Additional information

RNS Number : 8510A

Societe Generale SA

04 June 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	UDG Healthcare plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	€0.05 ordinary shares
Date of dealing	03/06/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	4,087,029	1.62	4,984	0.00
(2) Derivatives (other than options)	0	0.00	0	0.00
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*4,147,029	*1.65	4,984	0.00

* Include the holding of 60,000 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit GBP (Note 5)
Purchase	22	10.58
Purchase	200	10.58
Purchase	56	10.59
Purchase	661	10.59
Purchase	661	10.59
Purchase	375	10.59
Purchase	212	10.58
Purchase	589	10.58
Purchase	136	10.58
Purchase	621	10.58
Purchase	334	10.6
Purchase	2,655	10.6
Purchase	321	10.57
Purchase	301	10.57
Purchase	411	10.58
Purchase	313	10.57
Purchase	304	10.55
Purchase	299	10.55
Purchase	302	10.56
Purchase	716	10.58
Purchase	337	10.57
Purchase	57	10.56
Purchase	299	10.57
Purchase	321	10.57
Purchase	330	10.57
Purchase	295	10.57
Purchase	339	10.58
Purchase	306	10.57
Purchase	306	10.55
Purchase	358	10.57
Purchase	199	10.57
Purchase	116	10.57
Purchase	304	10.57
Purchase	302	10.57
Purchase	317	10.57
Purchase	303	10.57
Purchase	307	10.57
Purchase	305	10.57
Purchase	304	10.57
Purchase	358	10.56
Purchase	204	10.56
Purchase	301	10.57
Purchase	329	10.57
Purchase	305	10.57
Purchase	318	10.56
Purchase	329	10.57
Purchase	333	10.58
Purchase	317	10.57
Purchase	138	10.57
Purchase	339	10.56
Purchase	320	10.57
Purchase	311	10.57
Purchase	308	10.58
Purchase	322	10.57
Purchase	305	10.58
Purchase	308	10.56
Purchase	308	10.55
Purchase	349	10.57
Purchase	328	10.57
Purchase	315	10.57
Purchase	303	10.56
Purchase	316	10.57
Purchase	308	10.58
Purchase	309	10.57
Purchase	311	10.57
Purchase	75	10.56
Purchase	305	10.55
Purchase	312	10.57
Purchase	118	10.57
Purchase	186	10.57
Purchase	302	10.57
Purchase	317	10.57
Purchase	330	10.56
Sale	286	10.57
Sale	516	10.57
Sale	245	10.58
Sale	137	10.58
Sale	49	10.57
Sale	162	10.57
Sale	1,300	10.57
Sale	1,414	10.57
Sale	549	10.59
Sale	200	10.57
Sale	3,821	10.57
Sale	4	10.57
Sale	26	10.57
Sale	1,093	10.57
Sale	88	10.57
Sale	917	10.57
Sale	65	10.57
Sale	334	10.58
Total Purchases	24,831
Total Sales	11,206

Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit GBP (Note 5)

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements, or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	04/06/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEUPUGUQUPGUAC